Macrolide-resistant Mycoplasma pneumoniae in humans, Ontario, Canada, 2010-2011
- PMID: 23968896
- PMCID: PMC3810904
- DOI: 10.3201/eid1909.121466
Macrolide-resistant Mycoplasma pneumoniae in humans, Ontario, Canada, 2010-2011
Abstract
Antimicrobial drug resistance rates for Mycoplasma pneumoniae was determined in clinical specimens and isolates obtained during 2011-2012 in Ontario, Canada. Of 91 M. pneumoniae drug-resistant specimens, 11 (12.1%) carried nucleotide mutations associated with macrolide resistance in the 23S rRNA gene. None of the M. pneumoniae specimens were resistant to fluoroquinolones or tetracyclines.
Keywords: Canada; Mycoplasma pneumoniae; Ontario; antibiotic resistance; antimicrobial resistance; bacteria; community-acquired pneumonia; macrolide resistance; macrolides.
References
-
- Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harrison C, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011;53:617–30. 10.1093/cid/cir625 - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical